The Jackson Laboratory
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1929-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.jax.org
Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
- Conditions
- AgingVaccine ResponseInfluenza VaccineDendritic Cell
- Interventions
- Biological: Flu Vaccine (Year 1)Biological: Flu Vaccine (Year 2)Biological: Flu Vaccine (Year 3)
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- The Jackson Laboratory
- Target Recruit Count
- 66
- Registration Number
- NCT05518500
- Locations
- 🇺🇸
UConn Health, Center On Aging, Farmington, Connecticut, United States
Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
- Conditions
- PneumoniaAging
- Interventions
- Biological: Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein
- First Posted Date
- 2017-04-07
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- The Jackson Laboratory
- Target Recruit Count
- 40
- Registration Number
- NCT03104075
- Locations
- 🇺🇸
UConn Center On Aging, Farmington, Connecticut, United States
News
The Jackson Laboratory Acquires New York Stem Cell Foundation to Accelerate Precision Medicine Discovery
The Jackson Laboratory has completed its acquisition of the New York Stem Cell Foundation, creating a powerful nonprofit platform that combines genetics, stem cell science, and AI-driven analytics for biomedical discovery.
Kernal Bio Secures $48 Million ARPA-H Grant to Develop Revolutionary In Vivo CAR-T Cell Therapies
Kernal Bio received up to $48 million from ARPA-H to advance its in vivo CAR-T cell therapy program KR-402, targeting multiple sclerosis and B-cell malignancies including acute lymphoblastic leukemia and large B-cell lymphoma.